Bayesian Design of Superiority Trials: Methods and Applications

被引:2
|
作者
Yuan, Wenlin [1 ]
Chen, Ming-Hui [1 ]
Zhong, John [2 ]
机构
[1] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA
[2] REGENXBIO Inc, Rockville, MD USA
来源
STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 2022年 / 14卷 / 04期
关键词
Borrowing-by-parts power prior; Conditional borrowing; Power prior; Sample size determination; SAMPLE-SIZE DETERMINATION; HISTORICAL CONTROL DATA; CLINICAL-TRIALS; SURVIVAL-DATA; MODEL; INFORMATION; DUCHENNE; PRIORS;
D O I
10.1080/19466315.2022.2090429
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this article, we lay out the basic elements of Bayesian sample size determination (SSD) for the Bayesian design of a two-arm superiority clinical trial. We develop a flowchart of the Bayesian SSD that highlights the critical components of a Bayesian design and provides a practically useful roadmap for designing a Bayesian clinical trial in real world applications. We empirically examine the amount of borrowing, the choice of noninformative priors, and the impact of model misspecification on the Bayesian Type I error and power. A formal and statistically rigorous formulation of conditional borrowing within the decision rule framework is developed. Moreover, by extending the partial borrowing power priors, a new borrowing-by-parts power prior for incorporating historical data is proposed. Computational algorithms are also developed to calculate the Bayesian Type I error and power. Extensive simulation studies are carried out to explore the operating characteristics of the proposed Bayesian design of a superiority trial.
引用
收藏
页码:433 / 443
页数:11
相关论文
共 50 条
  • [41] Bayesian randomized clinical trials: From fixed to adaptive design
    Yin, Guosheng
    Lam, Chi Kin
    Shi, Haolun
    CONTEMPORARY CLINICAL TRIALS, 2017, 59 : 77 - 86
  • [42] Bayesian local exchangeability design for phase II basket trials
    Liu, Yilin
    Kane, Michael
    Esserman, Denise
    Blaha, Ondrej
    Zelterman, Daniel
    Wei, Wei
    STATISTICS IN MEDICINE, 2022, 41 (22) : 4367 - 4384
  • [43] Bayesian design and analysis of 2 by 2 factorial clinical trials
    Simon, R
    Freedman, LS
    AMERICAN STATISTICAL ASSOCIATION - 1996 PROCEEDINGS OF THE SECTION ON BAYESIAN STATISTICAL SCIENCE, 1996, : 180 - 185
  • [44] Bayesian design of clinical trials using joint models for longitudinal and time-to-event data
    Xu, Jiawei
    Psioda, Matthew A.
    Ibrahim, Joseph G.
    BIOSTATISTICS, 2022, 23 (02) : 591 - 608
  • [45] Bayesian design using adult data to augment pediatric trials
    Schoenfeld, David A.
    Zheng, Hui
    Finkelstein, Dianne M.
    CLINICAL TRIALS, 2009, 6 (04) : 297 - 304
  • [46] Adaptive group sequential design for phase II clinical trials: A Bayesian decision theoretic approach
    Chen, Yiyi
    Smith, Brian J.
    STATISTICS IN MEDICINE, 2009, 28 (27) : 3347 - 3362
  • [47] Bayesian Hypothesis Testing in Two-Arm Trials with Dichotomous Outcomes
    Zaslavsky, Boris G.
    BIOMETRICS, 2013, 69 (01) : 157 - 163
  • [48] Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products
    Gamalo, Meg A.
    Tiwari, Ram C.
    LaVange, Lisa M.
    PHARMACEUTICAL STATISTICS, 2014, 13 (01) : 25 - 40
  • [49] Understanding superiority, noninferiority, and equivalence for clinical trials
    Kishore, Kamal
    Mahajan, Rahul
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (06) : 890 - 894
  • [50] More multiarm randomised trials of superiority are needed
    Parmar, Mahesh K. B.
    Carpenter, James
    Sydes, Matthew R.
    LANCET, 2014, 384 (9940) : 283 - 284